Theratechnologies PEG
Что обозначает PEG в Theratechnologies?
PEG Theratechnologies, Inc. является 740.91
Какое определение для PEG?
Соотношение цена / прибыль к росту (PEG) - это отношение «цена / прибыль», деленное на прогнозируемые темпы роста прибыли компании за период в 5 лет.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG компаний в Health Care сектор на TSX по сравнению с Theratechnologies
Что делает Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Компании с peg похож на Theratechnologies
- CenturyLink имеет PEG из 419.23
- Tuniu Corp имеет PEG из 453.00
- Western Digital имеет PEG из 490.33
- Alexandria Real Estate Equities имеет PEG из 537.70
- SFC AG имеет PEG из 556.47
- Oxford Immunotec Global PLC имеет PEG из 588.67
- Theratechnologies имеет PEG из 740.91
- Hathway Cable and Datacom имеет PEG из 770.00
- Upwork Inc имеет PEG из 793.75
- Apartment Investment & Management Co имеет PEG из 839.32
- Knight Therapeutics имеет PEG из 861.00
- HealthCare Global Enterprises имеет PEG из 1,059.90
- Shionogi & Co имеет PEG из 24,611.80